Intellectual Property Cases filed in Delaware
Cases 51 - 60 of 92
Salix Pharmaceuticals Ltd. et al v. Par Pharmaceutical Companies Inc. et al
as 1:2014cv00946
Plaintiff: Salix Pharmaceuticals Ltd. , Salix Pharmaceuticals Inc. and Glycyx Pharmaceuticals Ltd.
Defendant: Par Pharmaceutical Companies Inc. and Par Pharmaceutical Inc.
Counter_claimant: Par Pharmaceutical Inc. and Par Pharmaceutical Companies Inc.
Counter_defendant: Glycyx Pharmaceuticals Ltd. , Salix Pharmaceuticals Inc. and Salix Pharmaceuticals Ltd.
Cause Of Action: 35 U.S.C. § 271
AstraZeneca AB v. Par Pharmaceutical Inc.
as 1:2014cv00845
Plaintiff: AstraZeneca AB
Defendant: Par Pharmaceutical Inc.
Counter_claimant: Par Pharmaceutical Inc.
Counter_defendant: AstraZeneca AB
Cause Of Action: 35 U.S.C. § 271
Par Pharmaceutical Inc. v. Novartis Pharmaceuticals Corporation et al
as 1:2014cv00843
Plaintiff: Par Pharmaceutical Inc.
Defendant: Novartis Pharmaceuticals Corporation, Novartis AG, Novartis Pharma AG and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Otsuka Pharmaceutical Co. Ltd. v. Par Pharmaceutical Inc.
as 1:2014cv00789
Plaintiff: Otsuka Pharmaceutical Co. Ltd.
Defendant: Par Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer Pharma AG et al v. Par Pharmaceutical Inc. et al
as 1:2014cv00761
Plaintiff: Bayer Pharma AG , Bayer Intellectual Property GMBH and Bayer HealthCare Pharmaceuticals Inc.
Defendant: Par Pharmaceutical Inc. and Par Pharmaceutical Companies Inc.
Cause Of Action: 35 U.S.C. § 271
Reckitt Benckiser Pharmaceuticals Inc. et al v. Par Pharmaceutical Inc. et al
as 1:2014cv00422
Plaintiff: Reckitt Benckiser Pharmaceuticals Inc. , RB Pharmaceuticals Limited and MonoSol Rx LLC
Defendant: Par Pharmaceutical Inc. and IntelGenX Technologies Corp.
Cause Of Action: 35 U.S.C. § 271
Forest Laboratories Inc. et al v. Apotex Corp. et al
as 1:2014cv00200
Plaintiff: Forest Laboratories Inc. , Forest Laboratories Holdings Ltd. and Adamas Pharmaceuticals Inc.
Defendant: Apotex Corp. , Apotex Inc. , Zydus Pharmaceuticals (USA) Inc. and others
Cause Of Action: 35 U.S.C. § 271
Otsuka Pharmaceutical Co. Ltd. v. Par Pharmaceutical Inc.
as 1:2013cv01979
Plaintiff: Otsuka Pharmaceutical Co. Ltd.
Defendant: Par Pharmaceutical Inc.
Counter_claimant: Par Pharmaceutical Inc.
Counter_defendant: Otsuka Pharmaceutical Co. Ltd.
Cause Of Action: 35 U.S.C. § 271
Forest Laboratories Inc. et al v. Par Pharmaceutical Inc.
as 1:2013cv01606
Plaintiff: Forest Laboratories Inc. , Forest Laboratories Holdings Ltd. and Royalty Pharma Collection Trust
Defendant: Par Pharmaceutical Inc.
Counter_claimant: Par Pharmaceutical Inc.
Counter_defendant: Forest Laboratories Holdings Ltd. , Forest Laboratories Inc. and Royalty Pharma Collection Trust
Cause Of Action: 35 U.S.C. § 271
Takeda Pharmaceuticals USA Inc. v. Par Pharmaceutical Companies Inc. et al We have downloadable decisions or orders for this case
as 1:2013cv01524
Plaintiff: Takeda Pharmaceuticals USA Inc.
Defendant: Par Pharmaceutical Companies Inc. and Par Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?